PubMed COVID-19 Clinical Care
1131 - 1140 of 2101 results found
Massive-scale genomic analysis reveals SARS-CoV-2 mutation characteristics and evolutionary trends
Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic resulted in significant societal costs. Hence, an in-depth understanding of SARS-CoV-2 virus mutation and its evolution will help determine the direction of the COVID-19
Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report
Description
During the Coronavirus disease 2019 (COVID-19) pandemic, vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has proven to be an important measure to help control disease spread and improve patient outcome. There are four
More Than Results: The Clinical and Research Relationship in the Evolving Detection and Surveillance of SARS-CoV-2
Description
CONCLUSIONS: Measures of Ct value in RT-PCR diagnostic assays combined with routine screening have valuable applications in monitoring the dynamics of SARS-CoV-2 within communities.
Mental Health Status, Risk and Protective Factors for Healthcare Staff Prior to the First Major COVID-19 Outbreak in Western Australia
Description
Objectives: Western Australia's unique public health response delayed the first wave of community COVID-19 transmission for 2 years. We aimed to determine the status of post-traumatic stress (PTSS), depressive, and anxiety symptoms among healthcare
Mucormycosis: update on clinical presentation, diagnosis, and treatment
Description
PURPOSE OF REVIEW: Mucormycosis (MCR) is a common opportunistic mold infection, and Mucorales were recently designated by WHO as priority pathogens. The interest in this infection has risen significantly since the major outbreak of MCR in the context
Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection
Description
Little is known about the persistence of human milk anti-SARS-CoV-2 antibodies after 2^(nd) and 3^(rd) vaccine doses and infection following 3^(rd) dose. In this study, human milk, saliva, and blood samples were collected from 33 lactating
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Description
The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized to offer broader protection against COVID-19. We conducted a matched cohort study to evaluate the effectiveness of the bivalent vaccine in preventing
MEDICAL TREATMENT UNDER WITH- AND POST-COVID-19
Description
No abstract
